Literature DB >> 8386360

Solution structure of human corticotropin releasing factor by 1H NMR and distance geometry with restrained molecular dynamics.

C Romier1, J M Bernassau, C Cambillau, H Darbon.   

Abstract

The structure of human corticotropin releasing factor (hCRF) has been determined by proton nuclear magnetic resonance (1H NMR) in a mixed-solvent system of 66% trifluoroethanol/34% H2O at pH 3.8 and 37 degrees C. Nearly complete resonance assignment was achieved by using standard two-dimensional methods. Distance restraints for structure calculations were obtained by qualitative analysis of intra- and inter-residue nuclear Overhauser effects. Structures were obtained from the distance restraints by distance geometry, followed by refinement using molecular dynamics and were completed with amide hydrogen exchange data. The structure of hCRF in this solvent comprises an extended N-terminal tetrapeptide connected to a well-defined alpha-helix between residues 6 and 36. The first half of the alpha-helix (residues 6-20) is clearly amphipathic. The five carboxy-terminal residues are predominantly disordered.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8386360     DOI: 10.1093/protein/6.2.149

Source DB:  PubMed          Journal:  Protein Eng        ISSN: 0269-2139


  5 in total

1.  A single amino acid serves as an affinity switch between the receptor and the binding protein of corticotropin-releasing factor: implications for the design of agonists and antagonists.

Authors:  K Eckart; O Jahn; J Radulovic; H Tezval; L van Werven; J Spiess
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

2.  Potent, structurally constrained agonists and competitive antagonists of corticotropin-releasing factor.

Authors:  J Gulyas; C Rivier; M Perrin; S C Koerber; S Sutton; A Corrigan; S L Lahrichi; A G Craig; W Vale; J Rivier
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

3.  Genetically encoded chemical probes in cells reveal the binding path of urocortin-I to CRF class B GPCR.

Authors:  Irene Coin; Vsevolod Katritch; Tingting Sun; Zheng Xiang; Fai Yiu Siu; Michael Beyermann; Raymond C Stevens; Lei Wang
Journal:  Cell       Date:  2013-11-27       Impact factor: 41.582

4.  The binding protein of corticotropin-releasing factor: ligand-binding site and subunit structure.

Authors:  Olaf Jahn; Klaus Eckart; Olaf Brauns; Hossein Tezval; Joachim Spiess
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-05       Impact factor: 11.205

Review 5.  Targeting VIP and PACAP receptor signalling: new therapeutic strategies in multiple sclerosis.

Authors:  Yossan-Var Tan; James A Waschek
Journal:  ASN Neuro       Date:  2011-10-06       Impact factor: 4.146

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.